182 related articles for article (PubMed ID: 36591225)
1. Targeting heat shock proteins 90 and 70: A promising remedy for both autoimmune bullous diseases and COVID-19.
Kasperkiewicz M; Tukaj S
Front Immunol; 2022; 13():1080786. PubMed ID: 36591225
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to heat shock protein 60, 70, and 90 are not altered in the anti-SARS-CoV-2 IgG-seropositive humans without or with mild symptoms.
Mantej J; Bednarek M; Sitko K; Świętoń M; Tukaj S
Cell Stress Chaperones; 2021 Jul; 26(4):735-740. PubMed ID: 34080135
[TBL] [Abstract][Full Text] [Related]
3. Heat Shock Protein 90 (Hsp90) and Hsp70 as Potential Therapeutic Targets in Autoimmune Skin Diseases.
Tukaj S; Sitko K
Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009046
[TBL] [Abstract][Full Text] [Related]
4. Heat shock protein 90: a pathophysiological factor and novel treatment target in autoimmune bullous skin diseases.
Tukaj S; Zillikens D; Kasperkiewicz M
Exp Dermatol; 2015 Aug; 24(8):567-71. PubMed ID: 25980533
[TBL] [Abstract][Full Text] [Related]
5. Heat Shock Proteins: Therapeutic Perspectives in Inflammatory Disorders.
Khandia R; Munjal AK; Iqbal HMN; Dhama K
Recent Pat Inflamm Allergy Drug Discov; 2017; 10(2):94-104. PubMed ID: 27978789
[TBL] [Abstract][Full Text] [Related]
6. Covid-19, heat shock proteins, and autoimmune bullous diseases: a potential link deserving further attention.
Kasperkiewicz M
Cell Stress Chaperones; 2021 Jan; 26(1):1-2. PubMed ID: 33196989
[TBL] [Abstract][Full Text] [Related]
7. Severe acute respiratory syndrome coronavirus 2 infection in patients with autoimmune bullous diseases in China.
Zhang JL; Wang SH; Cui SN; Zhang J; Li SZ; Li L; Zuo YG
J Dermatol; 2023 Nov; 50(11):1433-1441. PubMed ID: 37501390
[TBL] [Abstract][Full Text] [Related]
8. Adverse outcome and severity of COVID-19 in patients with autoimmune bullous diseases: A historical cohort study.
Moghadam FS; Kianfar N; Dasdar S; Samii R; Farimani Z; Azar PM; Balighi K; Abedini R; Soori T; Farid AS; Mahmoudi H; Daneshpazhooh M
Dermatol Ther; 2022 Sep; 35(9):e15672. PubMed ID: 35768959
[TBL] [Abstract][Full Text] [Related]
9. Heat shock protein 90 inhibition: A potential double- or triple-edged sword in the treatment of mucous membrane pemphigoid.
Kasperkiewicz M; Płatkowska A; Zalewska A; Zillikens D
Med Hypotheses; 2015 Oct; 85(4):412-4. PubMed ID: 26152650
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of adjuvant-induced arthritis by DNA vaccination with the 70-kd or the 90-kd human heat-shock protein: immune cross-regulation with the 60-kd heat-shock protein.
Quintana FJ; Carmi P; Mor F; Cohen IR
Arthritis Rheum; 2004 Nov; 50(11):3712-20. PubMed ID: 15529360
[TBL] [Abstract][Full Text] [Related]
11. Elevated HSP70 and HSP90 as Predictive Markers of Immune Activation and Lung Injury in SARS-COV-2 Disease.
Zangeneh Z; Khamisipour G
Iran J Immunol; 2023 Sep; 3(20):368-373. PubMed ID: 37606151
[TBL] [Abstract][Full Text] [Related]
12. Role of Heat Shock Proteins (HSP70 and HSP90) in Viral Infection.
Lubkowska A; Pluta W; Strońska A; Lalko A
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502274
[TBL] [Abstract][Full Text] [Related]
13. Membrane-bound heat shock proteins facilitate the uptake of dying cells and cross-presentation of cellular antigen.
Zhu H; Fang X; Zhang D; Wu W; Shao M; Wang L; Gu J
Apoptosis; 2016 Jan; 21(1):96-109. PubMed ID: 26481477
[TBL] [Abstract][Full Text] [Related]
14. Anti-Hsp90 therapy in autoimmune and inflammatory diseases: a review of preclinical studies.
Tukaj S; Węgrzyn G
Cell Stress Chaperones; 2016 Mar; 21(2):213-8. PubMed ID: 26786410
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune mucocutaneous blistering diseases after SARS-Cov-2 vaccination: A Case report of Pemphigus Vulgaris and a literature review.
Calabria E; Canfora F; Mascolo M; Varricchio S; Mignogna MD; Adamo D
Pathol Res Pract; 2022 Apr; 232():153834. PubMed ID: 35278817
[TBL] [Abstract][Full Text] [Related]
16. Heat shock proteins and heat shock protein-antibody complexes in placental tissues.
Ziegert M; Witkin SS; Sziller I; Alexander H; Brylla E; Härtig W
Infect Dis Obstet Gynecol; 1999; 7(4):180-5. PubMed ID: 10449265
[TBL] [Abstract][Full Text] [Related]
17. Autoantibody against 70 kD heat shock protein in patients with autoimmune liver diseases.
Shingai R; Maeda T; Onishi S; Yamamoto Y
J Hepatol; 1995 Oct; 23(4):382-90. PubMed ID: 8655954
[TBL] [Abstract][Full Text] [Related]
18. Evolution of heat shock protein and immunity.
Robert J
Dev Comp Immunol; 2003; 27(6-7):449-64. PubMed ID: 12697304
[TBL] [Abstract][Full Text] [Related]
19. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96.
Ishii T; Udono H; Yamano T; Ohta H; Uenaka A; Ono T; Hizuta A; Tanaka N; Srivastava PK; Nakayama E
J Immunol; 1999 Feb; 162(3):1303-9. PubMed ID: 9973383
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a role of autoantibodies to heat shock protein 60, 70, and 90 in patients with dermatitis herpetiformis.
Kasperkiewicz M; Tukaj S; Gembicki AJ; Silló P; Görög A; Zillikens D; Kárpáti S
Cell Stress Chaperones; 2014 Nov; 19(6):837-43. PubMed ID: 24643797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
